benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution [Orasep Reformulated Dec 2013]
RxNorm concept 1547767, branded drug (sbd). Prescribable name: Orasep (2 % / 0.1 % / 0.5 % ) Mucous Membrane Topical Solution, Reformulated Dec 2013.
- RxCUI
- 1547767
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1547767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.5 % Mucous Membrane Topical Solution [Orasep Reformulated Dec 2013]
Related concepts
- benzocaine 20 MG/ML (SCDC, consists of)
- menthol 5 MG/ML (SCDC, consists of)
- cetylpyridinium chloride 1 MG/ML (SCDC, consists of)
- benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML [Orasep Reformulated Dec 2013] (SBDC, consists of)
- Mucous Membrane Topical Solution (DF, has dose form)
- Orasep Reformulated Dec 2013 (BN, has ingredient)
- benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucous Membrane Topical Solution (SCD, tradename of)
Linked data
NDCs
- 54859050301
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1547767 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1547767 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1547767. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.